Modulari-T Bioscience

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

Modulus Therapeutics

This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

ImmPACT Bio

This clinical-stage biotechnology company develops logic-gate-based chimeric antigen receptor T-cell therapies for patients with cancer and autoimmune diseases.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Sonoma Biotherapeutics

This biotechnology company develops engineered regulatory T cell therapies for patients with autoimmune and inflammatory diseases.

Arsenal Biosciences

This company develops programmable T-cell therapies to treat solid tumours and autoimmune diseases for patients with cancer and chronic illnesses.

Luminary Therapeutics

This biotechnology company develops cell therapies to treat patients with cancers and autoimmune diseases.